Sep 09, 2019 / 06:15PM GMT
Edmund Tu - Morgan Stanley, Research Division - Analyst
We have Chris Linthwaite, CEO of Fluidigm, on stage with me today. Vikram Jog, CFO, and Agnes Lee, VP of Investor Relations in the audience.
Before we get started, I just wanted to remind everyone that all disclosures pertaining to this conversation can be found on our disclosure website at www.morganstanley.com\researchdisclosures.
So Chris, very happy to have you here today. I have a series of questions prepared for you, but I think it'd be a good idea to start off with a high-level overview of your company for some of the investors in the room who might not be as familiar.
Stephen Christopher Linthwaite - Fluidigm Corporation - President, CEO & Director
Thank you, again. [Edmund], thank you very much for the invitation and for my extension Morgan Stanley for including Fluidigm in the Healthcare Conference.
I think Fluidigm is a company that's really, really interesting for a number of reasons. First, it's a company that's attacking a $3 billion market, we
Fluidigm Corp at Morgan Stanley Healthcare Conference Transcript
Sep 09, 2019
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers